 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, April 19, 2006, 26(16):4147-4154; doi:10.1523/JNEUROSCI.5461-05.2006
Previous Article | Next Article
Neurobiology of Disease
Overloading of Stable and Exclusion of Unstable Human Superoxide Dismutase-1 Variants in Mitochondria of Murine Amyotrophic Lateral Sclerosis Models
Daniel Bergemalm,1 P. Andreas Jonsson,1 Karin S. Graffmo,2 Peter M. Andersen,3 Thomas Brännström,2 Anna Rehnmark,1 andStefan L. Marklund1 Department of Medical Biosciences, 1Clinical Chemistry and 2Pathology and 3Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-901 85 Umeå, Sweden
Correspondence should be addressed to Stefan L. Marklund, Department of Medical Biosciences, Clinical Chemistry, Umeå University, SE-901 85 Umeå, Sweden. Email: stefan.marklund{at}medbio.umu.se
Mutants of human superoxide dismutase-1 (hSOD1) cause amyotrophic lateral sclerosis (ALS), and mitochondria are thought to be primary targets of the cytotoxic action. The high expression rates of hSOD1s in transgenic ALS models give high levels of the stable mutants G93A and D90A as well as the wild-type human enzyme, significant proportions of which lack Cu and the intrasubunit disulfide bond. The endogenous murine SOD1 (mSOD1) also lacks Cu and is disulfide reduced but is active and oxidized in mice expressing the low-level unstable mutants G85R and G127insTGGG. The possibility that the molecular alterations may cause artificial loading of the stable hSOD1s into mitochondria was explored. Approximately 10% of these hSOD1s were localized to mitochondria, reaching levels 100-fold higher than those of mSOD1 in control mice. There was no difference between brain and spinal cord and between stable mutants and the wild-type hSOD1. mSOD1 was increased fourfold in mitochondria from high-level hSOD1 mice but was normal in those with low levels, suggesting that the Cu deficiency and disulfide reduction cause mitochondrial overloading. The levels of G85R and G127insTGGG mutant hSOD1s in mitochondria were 100- and 1000-fold lower than those of stable mutants. Spinal cords from symptomatic mice contained hSOD1 aggregates covering the entire density gradient, which could contaminate isolated organelle fractions. Thus, high hSOD1 expression rates can cause artificial loading of mitochondria. Unstable low-level hSOD1s are excluded from mitochondria, indicating other primary locations of injury. Such models may be preferable for studies of ALS pathogenesis.
Key words: amyotrophic lateral sclerosis; mitochondria; superoxide dismutase; transgenic mice; Cu; disulfide bond
Received Dec. 21, 2005; revised Feb. 23, 2006; accepted March 8, 2006.
Correspondence should be addressed to Stefan L. Marklund, Department of Medical Biosciences, Clinical Chemistry, Umeå University, SE-901 85 Umeå, Sweden. Email: stefan.marklund{at}medbio.umu.se
This article has been cited by other articles:
D. Bergemalm, K. Forsberg, P. A. Jonsson, K. S. Graffmo, T. Brannstrom, P. M. Andersen, H. Antti, and S. L. Marklund
Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis
Mol. Cell. Proteomics, June 1, 2009; 8(6): 1306 - 1317.
[Abstract] [Full Text] [PDF]
L. Wang, H.-X. Deng, G. Grisotti, H. Zhai, T. Siddique, and R. P. Roos
Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse
Hum. Mol. Genet., May 1, 2009; 18(9): 1642 - 1651.
[Abstract] [Full Text] [PDF]
H. Kawamata and G. Manfredi
Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria
Hum. Mol. Genet., November 1, 2008; 17(21): 3303 - 3317.
[Abstract] [Full Text] [PDF]
M. Urushitani, S. A. Ezzi, A. Matsuo, I. Tooyama, and J.-P. Julien
The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS
FASEB J, July 1, 2008; 22(7): 2476 - 2487.
[Abstract] [Full Text] [PDF]
C. Vande Velde, T. M. Miller, N. R. Cashman, and D. W. Cleveland
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
PNAS, March 11, 2008; 105(10): 4022 - 4027.
[Abstract] [Full Text] [PDF]
D. Jaarsma, E. Teuling, E. D. Haasdijk, C. I. De Zeeuw, and C. C. Hoogenraad
Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice
J. Neurosci., February 27, 2008; 28(9): 2075 - 2088.
[Abstract] [Full Text] [PDF]
J.-L. Gonzalez de Aguilar, C. Niederhauser-Wiederkehr, B. Halter, M. De Tapia, F. Di Scala, P. Demougin, L. Dupuis, M. Primig, V. Meininger, and J.-P. Loeffler
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model
Physiol Genomics, January 17, 2008; 32(2): 207 - 218.
[Abstract] [Full Text] [PDF]
P. Zetterstrom, H. G. Stewart, D. Bergemalm, P. A. Jonsson, K. S. Graffmo, P. M. Andersen, T. Brannstrom, M. Oliveberg, and S. L. Marklund
Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models
PNAS, August 28, 2007; 104(35): 14157 - 14162.
[Abstract] [Full Text] [PDF]
T. Bordet, B. Buisson, M. Michaud, C. Drouot, P. Galea, P. Delaage, N. P. Akentieva, A. S. Evers, D. F. Covey, M. A. Ostuni, et al.
Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 709 - 720.
[Abstract] [Full Text] [PDF]
J. Wang, A. Caruano-Yzermans, A. Rodriguez, J. P. Scheurmann, H. H. Slunt, X. Cao, J. Gitlin, P. J. Hart, and D. R. Borchelt
Disease-associated Mutations at Copper Ligand Histidine Residues of Superoxide Dismutase 1 Diminish the Binding of Copper and Compromise Dimer Stability
J. Biol. Chem., January 5, 2007; 282(1): 345 - 352.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|